AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Z11 Trial and the Amorous Trial in Breast Surgery
In the past, everyone with breast cancer would just get an axillary dissection. But say for example, the patient ends up having a sentinel lymph node that's positive. What would we do in that case? And is there any data now to show that we don't need to do an actually no dissection like we used to 10, 15 years ago? Right. So based on the Z11 trial, if this patient who had a T2 tumor that was clinically node negative and underwent a lumpectomy and a sentinel node biopsy and had just one positive sentinel node, she would not need to undergo an axillarydissection.